Inhalant-Related Disorders: Types, Symptoms & Treatment

Inhalant-related disorders involve the intentional inhalation of volatile substances (e.g., glue, paint thinner, nitrous oxide) to achieve intoxication, leading to significant health risks and potential dependence. The DSM-5 classifies these disorders under Other (or Unknown) Substance-Related Disorders, as inhalants do not have their own category.

1. Inhalant Use Disorder

DSM-5 Criteria (≥2 symptoms within 12 months)

  • Impaired Control: Using more/longer than intended.
  • Cravings: Strong urge to use inhalants.
  • Tolerance: Needing more to achieve the same effect.
  • Withdrawal: Rare but possible (e.g., irritability, headaches).
  • Neglected Responsibilities: Work, school, or home life suffers.
  • Continued Use Despite Harm: Physical/mental health declines.

Severity Levels:

  • Mild (2–3 symptoms)
  • Moderate (4–5 symptoms)
  • Severe (6+ symptoms)

At-Risk Populations:

  • Adolescents (due to easy access and low cost).
  • Individuals in marginalized communities with limited substance access.

2. Inhalant Intoxication

Symptoms (Within Minutes of Use):

  • Euphoria, dizziness, slurred speech.
  • Impaired coordination, hallucinations.
  • Nausea, vomiting, headaches.
  • “Sudden Sniffing Death Syndrome” (SSDS): Fatal cardiac arrhythmia from acute use.

Common Inhalants:

  • Solvents (toluene, acetone) – Paint thinner, glue.
  • Gases (nitrous oxide, butane) – Whippets, lighter fluid.
  • Aerosols (spray paint, deodorants).

3. Inhalant Withdrawal

Note: Withdrawal is rare but may occur with chronic use.

Symptoms (Days After Stopping):

  • Irritability, anxiety, insomnia.
  • Tremors, sweating, nausea.
  • Cravings for the substance.

4. Inhalant-Induced Disorders

  • Psychotic Disorder: Delusions/hallucinations during/after use.
  • Neurocognitive Disorder: Memory loss, reduced IQ (chronic use).
  • Mood/Anxiety Disorders: Depression or panic symptoms.

Long-Term Health Risks:

  • Brain damage (white matter deterioration).
  • Liver/kidney damage.
  • Peripheral neuropathy (nerve damage).

Treatment Options

1. Medical Interventions

  • Acute intoxication: Supportive care (oxygen, monitoring).
  • Neuroprotective agents (under research).

2. Behavioral Therapies

  • Cognitive Behavioral Therapy (CBT): Address triggers & coping skills.
  • Motivational Interviewing (MI): Encourage abstinence.
  • Family therapy: Critical for adolescent users.

3. Harm Reduction (If Abstinence Fails)

  • Supervised use environments (rare, but considered in extreme cases).
  • Education on safer alternatives (though abstinence is ideal).

When to Seek Help

✔ Frequent inhalant use, especially in teens.
✔ Memory problems, mood swings, or personality changes.
✔ Signs of organ damage (jaundice, numbness).

Emergency Situations:

  • Seizures or loss of consciousness after use.
  • Chest pain or irregular heartbeat (risk of SSDS).